Pediatric osteosarcoma
MONDO:0002623An osteosarcoma occurring in childhood.
Also known as: osteosarcoma, childhood osteogenic sarcoma, childhood osteosarcoma, childhood osteosarcoma (disease), osteosarcoma (disease) of childhood, paediatric osteosarcoma (disease), pediatric osteosarcoma, pediatric osteosarcoma (disease)
2928 clinical trials for this condition and its sub-types, 8 tagged with Pediatric osteosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Pediatric osteosarcoma
-
Childhood extraosseous osteosarcoma 0 trials
-
Childhood intracortical osteosarcoma 0 trials
-
Childhood parosteal osteosarcoma 0 trials
-
Engineered immune cells take on childhood cancers that Won't quit
Disease control PausedThis phase 1 trial is testing a new treatment called GD2CART for children and young adults with osteosarcoma or neuroblastoma that has returned or does not respond to standard treatments. GD2CART is made by taking a patient's own T cells (a type of immune cell), adding a new gene…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New combo tackles returning bone cancer before surgery
Disease control OngoingThis early-phase trial tests the safety and effectiveness of the immune drug nivolumab (Opdivo) alone or combined with the chemo drug azacitidine (Vidaza) in people whose osteosarcoma has come back and can be surgically removed. About 21 participants will receive the drugs before…
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New combo therapy shows promise for tough bone cancer
Disease control OngoingThis study tests whether combining two drugs, regorafenib and nivolumab, can help people with osteosarcoma (a type of bone cancer) that has returned or not responded to previous treatments. About 48 participants aged 5 and older will receive the combination. The main goal is to s…
Phase 2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC